Skip to content
healthcare.dev

Polyethylene Glycol 3350

NDC 72657-196, Polyethylene Glycol 3350, powder, for solution, from GLENMARK THERAPEUTICS INC., USA.

Product NDC
72657-196
Status
Listed
Labeler
GLENMARK THERAPEUTICS INC., USA
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA203928
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72657-196 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYETHYLENE GLYCOL 335017 g/17g

Pharmacologic classes

Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
72657-196-1672657019616765 g in 1 CAN (72657-196-16)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 72657-196 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72657-196 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72657-196. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.